Skip to Content

Notice

Cooperative Research and Development Agreement (CRADA) Opportunity With the Department of Homeland Security for the Development of a Foot-and-Mouth Disease 3ABC ELISA Diagnostic Kit; Correction

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Science and Technology Directorate, Plum Island Animal Disease Center, Department of Homeland Security.

ACTION:

Notice of intent; correction.

SUMMARY:

The Department of Homeland Security Science and Technology Directorate (DHS S&T), through its Plum Island Animal Disease Center (PIADC), published a document in the Federal Register of May 16, 2013, seeking industry collaborators to aid DHS S&T in developing and validating an ELISA diagnostic kit for detection of Foot and Mouth Disease Virus (FMDV) non-structural proteins. The document did not specify dates for when the submission of proposals are due.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Angela Ervin, 202-254-5624.

Correction

In the Federal Register of May 16, 2013, in FR Doc. DHS-2013-0036, on page 1, in the third column, correct the DATES caption to read:

End Further Info

DATES:

Submit proposals on or before August 8, 2013.

Correction

In the Federal Register of May 16, 2013, in FR Doc. DHS-2013-0036, on Start Printed Page 42533page 1, in the third column, correct the ADDRESSES caption to read:

ADDRESSES:

Mail comments and requests to participate to Dr. Angela Ervin, (ATTN: Angela Ervin, 245 Murray Lane SW., Washington, DC 20528-0075). Submit electronic proposals, along with comments and other data to Angela.Ervin@hg.dhs.gov on or before August 8, 2013.

Start Signature

Dated: July 8, 2013.

James Johnson,

Director, Office of National Laboratories.

End Signature End Preamble

[FR Doc. 2013-16952 Filed 7-15-13; 8:45 am]

BILLING CODE 9910-9F-P